Abbott Laboratories (ABT) Stake Raised by Benjamin F. Edwards & Company Inc

The institutional investor held 136,238 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $7.27M, down from 142,097 at the end of the previous reported quarter. Following the completion of the sale, the insider now directly owns 10,256 shares in the company, valued at $572,900.16. Microsoft Corporation (NASDAQ:MSFT) has risen 34.52% since February 15, 2017 and is uptrending. It has underperformed by 23.20% the S&P500.

Integrys Wealth Advisors Llc decreased its stake in Abbott Labs (ABT) by 14.78% based on its latest 2017Q3 regulatory filing with the SEC. Wilen Investment Management Corp bought 21,521 shares as the company's stock rose 27.98% with the market. About 5.82 million shares traded. Prospector Partners LLC's holdings in Abbott Laboratories were worth $6,793,000 as of its most recent SEC filing.

Abbott Laboratories (NYSE:ABT) increasing 1.11% to trade at $58.28. Janus Henderson Group PLC raised its position in shares of Abbott Laboratories by 3,373.9% during the second quarter.

Abbott Laboratories (NYSE:ABT) last issued its quarterly earnings data on Wednesday, January 24th. It has underperformed by 0.80% the S&P500. Contreras Jaime had sold 52,700 shares worth $2.74 million. $1.56M worth of Abbott Laboratories (NYSE:ABT) was sold by Salvadori Daniel Gesua Sive. The insider Ford Robert B sold $2.69M.

Investors sentiment decreased to 0.87 in 2017 Q3. Its up 0.10, from 1.28 in 2017Q2. It worsened, as 47 investors sold ABT shares while 563 reduced holdings. Heritage Trust Co raised its stake in shares of Abbott Laboratories by 10.1% in the second quarter. Finally, Motco raised its stake in shares of Abbott Laboratories by 213.7% in the second quarter. 18,798 were accumulated by Indiana Tru & Investment Management Com. Oregon-based Ims Cap Mngmt has invested 0.65% in Abbott Laboratories (NYSE:ABT). Brinker Cap Inc accumulated 146,783 shares or 0.32% of the stock. Wetherby Asset Incorporated invested 0.3% in Abbott Laboratories (NYSE:ABT). Lazard Asset Ltd Liability Com, a New York-based fund reported 100 shares. Busey holds 0.16% of its portfolio in Abbott Laboratories (NYSE:ABT) for 25,824 shares. Beach Investment Management LLC. raised its stake in Abbott Laboratories by 2,161.4% in the second quarter. Nbt Bancorp N A Ny reported 119,004 shares. The California-based Old West Invest Mgmt has invested 5.58% in Abbott Laboratories (NYSE:ABT).

Among 4 analysts covering Kraton Performance Polymers (NYSE:KRA), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive.

Abbott Laboratories (NYSE:ABT) touched its 1-Year High price of $64.60 on 01/25/18 and its 1-Year Low price of $42.31 on 04/17/17. The share price has moved forward from its 20 days moving average, trading at a distance of 24.61% and stays 30.39% away from its 50 days moving average.

Abbott Laboratories's Average Earnings Estimate for the current quarter is $0.58, according to consensus of 19 analysts. The shares were sold at an average price of $55.55, for a total transaction of $1,325,756.30.

When we look at the Analyst Recommendations of the stock, the company has 1.43 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell. The stock of Kraton Corporation (NYSE:KRA) has "Hold" rating given on Friday, September 1 by KeyBanc Capital Markets. (NYSE:STNG) earned "Buy" rating by Jefferies on Monday, July 3. On Thursday, September 7 the stock rating was maintained by Jefferies with "Buy".

Abbott Laboratories (NYSE:ABT) has price to earnings growth of 24.41, which is a valuation metric for determining relative trade-off among price of a stock. As per Tuesday, August 15, the company rating was maintained by Cowen & Co. Jefferies maintained the shares of ABT in report on Friday, June 16 with "Buy" rating. Barclays Capital maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, January 25. The Foyston Gordon & Payne Inc holds 397,213 shares with $29.59M value, up from 312,037 last quarter. United Technologies Corp Com (NYSE:UTX) was reduced too.

Since September 18, 2017, it had 0 buys, and 3 sales for $1.60 million activity. Inc. now owns 2,463 shares of the healthcare product maker's stock worth $120,000 after purchasing an additional 370 shares during the last quarter. 489 shares were sold by RICE LINDA JOHNSON, worth $36,342.

Investors sentiment increased to 1.25 in Q3 2017. Its down 1.00, from 1 in 2017Q2. Sfe Invest Counsel invested in 126,855 shares. 65 funds opened positions while 203 raised stakes. John G Ullman And Assoc reported 2.83% stake. First Long Island Invsts Lc holds 419,046 shares or 3.24% of its portfolio. (NYSE:OMC) for 4,310 shares. This works out to a net increase in ownership of 8.77 million shares, and suggests that institutions are feeling bullish about the stock. Baldwin Brothers Inc Ma accumulated 0.03% or 3,038 shares. Moreover, Gemmer Asset Management Lc has 0% invested in Energizer Holdings, Inc. Mercer Capital Advisers has 349 shares for 0.01% of their portfolio.

Foyston Gordon & Payne Inc increased Microsoft Corp. Strs Ohio owns 1.35 million shares or 0.31% of their USA portfolio. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.69 and a quick ratio of 2.26. 113 are held by Whittier Trust Of Nevada Inc. Wall Street is only getting more bullish on the stock, with 7 of analysts who cover CSRA having a buy-equivalent rating. Omnicom had 43 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned "Overweight" rating on Tuesday, January 2 by JP Morgan. Barclays Capital maintained Abbott Laboratories (NYSE:ABT) on Thursday, April 20 with "Overweight" rating. As per Thursday, August 17, the company rating was initiated by Citigroup. Murphy Capital Mngmt reported 0.17% in Abbott Laboratories (NYSE:ABT). On Thursday, October 19 the stock rating was maintained by Morgan Stanley with "Equal-Weight".

Latest News